Solid Lipid Nanoparticles for Controlled Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (10 December 2022) | Viewed by 13545
Special Issue Editor
2. Department of Biopharmaceutical Engineering, 1 Gangwondaehak-gil, Seoksa-dong, Chuncheon-si 24341, Gangwon-do, Republic of Korea
Interests: controlled release; bioavailability; lipid-based nanoparticles; transdermal delivery; oral delivery; polymeric particulate system
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Solid lipid nanoparticles have been widely studied because they can be used in advanced drug delivery systems, offering characteristics such as sustained release, the encapsulation of versatile molecular compounds such as hydrophobic and hydrophilic molecules, high biocompatibility, and high biodegradability.
The Special Issue “Solid Lipid Nanoparticles and Controlled Drug Delivery” will deal with all aspects of the solid lipid nanoparticle-mediated delivery of therapeutic compounds. Therapeutic compounds include synthetic drugs and any biological agents. Articles that describe physicochemical properties, release profiles, in vitro cellular studies, and/or in vivo animal works are welcome.
Dr. Jong-Suep Baek
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- solid lipid nanoparticles (SLN)
- liposomes
- controlled drug delivery
- drug release
- nanocarriers
- nanomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.